Clinical and pharmacological aspects of the use of vitamin D: from the known facts to look for new targets
- Authors: Klimova O.Y.1, Berdnikova N.G1,2, Kazakov R.E3
-
Affiliations:
- I.M.Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation
- I.M.Davidovckiy City Clinical Hospital №23
- Scientific Center for Expertise of Pharmaceuticals for Medical Use of the Ministry of Health of the Russian Federation
- Issue: Vol 18, No 2 (2016)
- Pages: 109-116
- Section: Articles
- URL: https://journals.rcsi.science/2075-1753/article/view/94476
- ID: 94476
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
O. Yu Klimova
I.M.Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation
Email: oklimova2009@gmail.com
врач-эндокринолог, ассистент каф. клин. фармакологии и пропедевтики внутренних болезней ГБОУ ВПО Первый МГМУ им. И.М.Сеченова 119991, Russian Federation, Moscow, ul. Trubetskaia, d. 8, str. 2
N. G Berdnikova
I.M.Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation; I.M.Davidovckiy City Clinical Hospital №23
Email: berdnad@mail.ru
канд. мед. наук, доц. каф. клин. фармакологии и пропедевтики внутренних болезней ГБОУ ВПО Первый МГМУ им. И.М.Сеченова, врач - клинический фармаколог ГБУЗ ГКБ №23 им. И.В.Давыдовского 119027, Russian Federation, Moscow, ul. Iauzskaia, d. 11
R. E Kazakov
Scientific Center for Expertise of Pharmaceuticals for Medical Use of the Ministry of Health of the Russian Federation
Email: rustic100@rambler.ru
канд. биол. наук, нач. отд. персонализированной медицины и клин. фармакогенетики Центра клинической фармакологии ФГБУ НЦЭСМП 127051, Russian Federation, Moscow, Petrovskii b-r, d. 8
References
- Fukumoto S, Martin T.J. Bone as an endocrine organ. Trends Endocrinol Metab 2009; 20 (5): 230-6.
- Мелентьева А.А., Барышева О.Ю., Везикова Н.Н. и др. Роль фактора роста фибробластов 23 и фактора Klotho в развитии минерально - костных нарушений при хронической болезни почек. Курский научно - практ. вестн. «Человек и его здоровье». 2014; 3: 102-9.
- Гребенникова Т.А., Белая Ж.Е., Цориев Т.Т. и др. Эндокринная функция костной ткани. Остеопороз и остеопатии. 2015; 1: 28-37.
- Holick M.F. Vitamin D deficiency. N Engl J Med 2007; 357: 266-81.
- Heaney R.P. Functional indices of vitamin D status and ramifications of vitamin D deficiency. Am J Clin Nutr 2004; 80 (6): 1706S-1709S.
- Holick M.F, Binkley N.C et al. Weaver Evaluation, Treatment, and Prevention of Vitamin D. Deficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrin Metab 2011; 6: 1911-30
- Adams J.S, Hewison M. Update in vitamin D. J Clin Endocrinol Metab 2010; 95: 471-8.
- Holick M.F, Binkley N.C, Heike A et al. Guidelines for preventing and treating vitamin D deficiency and insufficiency revisited. J Clin Endocrinol Metab 2012; 97 (4): 1153-8.
- Клинические рекомендации. Дефицит витамина D у взрослых: диагностика, лечение и профилактика. Российская Ассоциация Эндокринологов. ФГБУ «Эндокринологический Научный Центр Министерства здравоохранения РФ». М., 2015 http://www.endocrincentr.ru/images/material-images/Rek_Vit%20D_2015.pdf
- IARC Working Group on Vitamin D: Vitamin D and Cancer. Report number 5. Geneva, Switzerland, WHO Press, 2008.
- Peterlik M, Boonen St, Cross H.S, Lamberg-Allardt C. Vitamin D and Calcium Insufficiency - Related Chronic Diseases: an Emerging World-Wide Public Health Problem. J Environ Res Public Health 2009; 6 (10): 2585-607. http://dx.doi.org/10.3390/ijerph6102585
- Grant W.B, Mohr S.F. Ecological studies of ultraviolet B, vitamin D and cancer since 2000. Ann Epidemiol 2009; 19: 446-54.
- Lappe J.M, Travers-Gustafson D, Davies K.M et al. And calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 2007; 85 (6): 1586-91.
- Kendrick J, Targher G, Smits G, Chonchol M. 25-Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Exam Surv Atheroscler 2009; 205 (1): 255-60.
- Егшатян Л.В., Дудинская Е.Н., Ткачева О.Н., Каштанова Д.А. Роль витамина D в патогенезе хронических неинфекционных заболеваний. Остеопороз и остеопатии. 2014; 1: 27-30.
- Li C, Qiao G, Uskokovic M et al. Vitamin D: a negative endocrine regulator of the reninangiotensin system and blood pressure. J of Steroid Bioch and Molec Biol 2004; 89-90 (1-5): 387-92.
- Afzal S, Nordestgaard B.G. Low vitamin D and hypertension: a causal association? 2014. www.thelancet.com/diabetes-endocrinology. http://dx.doi.org/10.1016/S2213-8587(14)70119-6
- Konradsen S, Ag H, Lindberg F et al. Serum 1.25-dihydroxy vitamin D is inversely associated with body mass index. Eur J Nutr 2008; 47 (2): 87-91.
- Scragg R, Sowers M, Bell C. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care 2004; 27: 2813-8.
- Chiu K.C, Chu A, Go V.L, Saad M.F. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 2004; 79 (5): 820-5.
- Harinarayan Ch.V. Vitamin D and diabetes mellitus. Hormones 2014; 13 (2): 163-81.
- Вельков В.В. С-реактивный белок - в лабораторной диагностике острых воспалений и в оценке рисков сосудистых патологий. Клинико - лабораторный консилиум. 2008; 2 (21): 37-48.
- Liu P.T, Stenger S, Li H et al. Vitamin D3-Triggered Antimicrobial Response - Another Pleiotropic Effect beyond Mineral and Bone Metabolism. Science 2006; 311: 1770-3.
- Chun R.F, Liu N.Q, Lee T et al. Vitamin D supplementation and antibacterial immune responses in adolescents and young adults with HIV/AIDS. J Steroid Biochem Mol Biol 2014; 8: 148. http://dx.doi.org/10.1016/j.jsbmb.2014.07.013
- Skaaby T, Nystrup Husemoen L.L, Thuesen B.H. Vitamin D Status and Chronic Obstructive Pulmonary Disease: A Prospective General Population Study. 2014; http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0090654
- Malinovschi А, Masoero М, Bellocchia М. Severe vitamin D deficiency is associated with frequent exacerbations and hospitalization in COPD patients. http://respiratory-research.com/content/15/1/131
- Ringe J.D et al. Alfacalcidol versus plain vitamin D in the treatment of glucocorticoid/inflammation - induced osteoporosis. J Rheumatol Suppl. 2005; 76: 33-40.
- Ringe J.D, Farahmand P, Schacht E. Alfacalcidol in men with osteoporosis: a prospective, observational, 2-year trial on 214 patients. Rheumatol Int 2013; 33 (3): 637-43.
- Скрипникова И.А. Предотвращение падений - один из способов профилактики переломов, связанных с остеопорозом // Неврология и ревматология. Приложение к Consilium Medicum. 2014; 16 (2): 66-70.
- Richy F, Dukas L, Schacht E. Differential effects of D-Hormone analogs and native vitamin D on the risk of falls: a comparative meta - analysis. Calcif Tissue Int 2008; 82: 102-7.
- Ito S, Harada A, Kasai T et al. Use of alfacalcidol in osteoporotic patients with low muscle mass might increase muscle mass: an investigation using a patient database. Geriatr Gerontol Int 2014; 14: 122-8.
- Hamdy N.A, Kanis J.A, Beneton M.N et al. Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure. BMJ 1995; 310 (6976): 358-63.
- Schact E, Richy F. Reduction of Falls in Elderly. The central role of Alfacalcidol in a multi - dimensional paradigm. Internet J Epidemiol 2008. http://ispub.com/IJE/7/1/5839
- Dobnig H, Pilz S, Scharnagl H et al. Independent Association of Low Serum 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D Levels With All-Cause and Cardiovascular Mortality. Arch Intern Med 2008; 168 (12): 1340-9. http://archinte.jamanetwork.com/
- Ярмолинская М.И. Постменопаузальный остеопороз: клиника, диагностика, профилактика, лечение. Спб., 2014; с. 30-5.
- Бердникова Н.Г. Клиническая фармакология лекарственных средств, применяющихся при остеопорозе. Глава 33. Клиническая фармакология и фармакотерапия: учебник. Под ред. В.Г.Кукеса, А.К.Стародубцева. 3-е изд., доп. и перераб. М.: ГЭОТАР-Медиа, 2011.
- Heller H.J. The role of calcium in the prevention of kidney stones. J Am Coll Nutr 1999; 18 (5 Suppl.): 373S-378S.
- Hall W.D, Pettinger M, Oberman A et al. Risk factors for kidney stones in older women in the southern United States. Am J Med Sci 2001; 322 (1): 12-8.
- Curban G.C, Willett W.C, Rimm E.B et al. A prospective study of dietary calcium and other nutrients and risk symptomatic kidney stones. N Engl J Med 1993; 328: 833-8.
- Генетический паспорт - основа индивидуальной и предиктивной медицины. Под ред. В.С.Баранова. Спб., 2009; с. 527.
- Mohammadi Z, Fayyazbakhsh F, Ebrahimi M et al. Association between vitamin D receptor gene polymorphisms (Fok1 and Bsm1) and osteoporosis: a systematic review. J Diabetes Metab Disord 2014; 13: 98.
- Xu C, Tang P, Ding C et al. Vitamin D Receptor Gene FOKI Polymorphism Contributes to Increasing the Risk of HIV-Negative Tuberculosis: Evidence from a Meta-Analysis. PLoS One. doi: 10.1371/journal.pone.0140634 October 20, 2015.
- Sei Won Kim, Jong Min Lee, Jick Hwan Ha et al. Association between vitamin D receptor polymorphisms and osteoporosis in patients with COPD. Int J COPD 2015; 10: 1809-17.
- Mc Carty M.F, Di Nicolantonio J.J. The molecular biology and pathophysiology of vascular calcification. Postgrad Med 2014; 126 (2): 54-64.
- Lewis J.R, Radavelli-Bagatini S, Rejnmark et al. The Effects of Calcium Supplementation on Verified Coronary Heart Disease Hospitalization and Death in Postmenopausal Women: A Collaborative Meta-Analysis of Randomized Controlled Trials. J Bone Miner Res 2014. doi: 10.1002/jbmr.2311.